0000899243-22-029178.txt : 20220818
0000899243-22-029178.hdr.sgml : 20220818
20220818170511
ACCESSION NUMBER: 0000899243-22-029178
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220817
FILED AS OF DATE: 20220818
DATE AS OF CHANGE: 20220818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sandler Andrew Seth
CENTRAL INDEX KEY: 0001596060
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37449
FILM NUMBER: 221178079
MAIL ADDRESS:
STREET 1: 1301 2ND AVE
CITY: SEATTLE
STATE: WA
ZIP: 98101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALPINE IMMUNE SCIENCES, INC.
CENTRAL INDEX KEY: 0001626199
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208969493
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 188 EAST BLAINE ST., SUITE 200
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: 206-788-4545
MAIL ADDRESS:
STREET 1: 188 EAST BLAINE ST., SUITE 200
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: Nivalis Therapeutics, Inc.
DATE OF NAME CHANGE: 20150211
FORMER COMPANY:
FORMER CONFORMED NAME: N30 Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20141121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-17
0
0001626199
ALPINE IMMUNE SCIENCES, INC.
ALPN
0001596060
Sandler Andrew Seth
C/O ALPINE IMMUNE SCIENCES, INC.
188 EAST BLAINE STREET, SUITE 200
SEATTLE
WA
98102
0
1
0
0
Chief Medical Officer
Stock Option (Right to buy)
8.38
2022-08-17
4
A
0
160000
0.00
A
2032-08-16
Common Stock
160000
160000
D
One-fourth (1/4th) of the shares subject to the option will vest on the one (1)-year anniversary of August 17, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Optionee continuing to be a Service Provider through each such date.
/s/ James Paul Rickey, attorney-in-fact
2022-08-18